[
    {
        "file_name": "AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement.pdf",
        "perturbation": [
            {
                "type": "Misaligned Terminology - Legal Contradiction",
                "original_text": "1.21 “Commercially Reasonable Efforts” means, with respect to the efforts to be expended by a Party with respect to any objective (e.g.,\nDevelopment Activities and Commercialization hereunder), the level of efforts consistent with the efforts and resources [***] of similar market potential,\nat a similar stage in development or product lifecycle, taking into account the stage of development or product lifecycle of other of [***] product\ncandidates, safety and efficacy, product profile, cost of goods, the competitiveness of the marketplace, such company’s patent position with respect to\nsuch product (including such company’s ability to obtain or enforce, or have obtained or enforced, such patent rights), the Third Party patent landscape\nrelevant to the product, the regulatory structure involved, the likelihood of regulatory approval, the likelihood and extent of anticipated or actual\nprofitability of the applicable product, and other technical, legal, scientific and medical considerations. Without limiting the foregoing, Commercially\nReasonable Efforts requires, with respect to such obligations, that a Party: (i) promptly assign responsibility for such obligation to specific employee(s)\nwho are held accountable for progress and monitor such progress on an on-going basis, (ii) set objectives for carrying out such obligations, and (iii)\nallocate resources designed to advance progress with respect to such objectives.",
                "changed_text": "1.21 “Commercially Reasonable Efforts” means, with respect to the efforts to be expended by a Party with respect to any objective (e.g.,\nDevelopment Activities and Commercialization hereunder), the level of efforts consistent with the efforts and resources [***] of similar market potential,\nat a similar stage in development or product lifecycle, taking into account the stage of development or product lifecycle of other of [***] product\ncandidates, safety and efficacy, product profile, cost of goods, the competitiveness of the marketplace, such company’s patent position with respect to\nsuch product (including such company’s ability to obtain or enforce, or have obtained or enforced, such patent rights), the Third Party patent landscape\nrelevant to the product, the regulatory structure involved, the likelihood of regulatory approval, the likelihood and extent of anticipated or actual\nprofitability of the applicable product, and other technical, legal, scientific and medical considerations. Without limiting the foregoing, Commercially\nReasonable Efforts requires, with respect to such obligations, that a Party: (i) may, at their discretion, assign responsibility for such obligation to specific employee(s)\nwho are held accountable for progress and monitor such progress on an on-going basis, (ii) may, at their discretion, set objectives for carrying out such obligations, and (iii)\nmay, at their discretion, allocate resources designed to advance progress with respect to such objectives.",
                "explanation": "Changing “shall” to “may, at their discretion” makes the Commercially Reasonable Efforts standard unenforceable. Contract law requires a certain level of mandatory behavior to be legally compliant.",
                "contradicted_law": "Contract Law - Enforceability of Obligation",
                "location": "Article 1.21"
            }
        ]
    }
]